This enabled us to define the diploid population for calculation of tumor ploidy for each cancer specimen and also allowed us to assess the impact of brca2 mutation on DNA content and cell cycle progression in nonneoplastic somatic cells. This evidence concerns the gene BRCA2 and cancer.